What Is the Global Laboratory Mouse Market Worth in 2026?

Laboratory Mouse by Type (Inbred Strains, Transgenic, Knockout, Other), by Application (Pharmaceutical Company, Hospital, Scientific Institutional Center, School, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Laboratory Mouse Market Size | CAGR 7.2 Forecast 2033

What Is the Global Laboratory Mouse Market Worth in 2026?

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $5200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Laboratory Mouse Market Overview

The Laboratory Mouse market comprises the production and supply of genetically defined mouse strains— inbred, outbred and transgenic— used as essential model organisms in biomedical research, drug discovery and toxicology. As a cornerstone of pre‑clinical studies, laboratory mice enable reproducible insights into disease mechanisms and therapeutic efficacy. Laboratory Mouse market size was estimated at approximately USD 2.8 billion in 2025, and industry analysts project a growth outlook with a compound annual growth rate (CAGR) of about 5.2% through the market forecast period 2026‑2033. This expansion is driven by rising R&D investments, increasing adoption of precision‑medicine approaches, and tighter regulatory mandates for animal‑based testing. Key forces shaping the sector include advances in CRISPR‑based genome editing, stricter animal welfare regulations, and intensified competition among global vendors to provide high‑quality, pathogen‑free colonies.

Loading chart…

Geographically, North America remains the largest market, anchored by extensive academic and pharmaceutical research infrastructures, while the Asia‑Pacific region is emerging as the fastest‑growing hub, propelled by expanding biotech ecosystems in China, Japan and South Korea. Supply‑chain dynamics—particularly the need for secure, cold‑chain logistics and pathogen‑free breeding facilities—are intensifying, prompting collaborations and vertical integration across the value chain. Collectively, these trends underscore a robust industry expansion trajectory, positioning the laboratory mouse sector as a strategic priority for stakeholders seeking to capitalize on next‑generation biomedical innovation.

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	9.07 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Jackson Laboratory; Charles River; Biolasco Taiwan; Taconic Biosciences; Envigo; JMSR; Janvier Labs; Shanghai SLAC Laboratory Animal; Beijing HFK Bioscience; Changzhou Cavens
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Laboratory Mouse market continues to evolve amid shifting scientific priorities, regulatory landscapes, and supply‑chain dynamics. Understanding the forces shaping market size and the forthcoming growth forecast is essential for executives steering portfolio strategy, investment decisions, and partnership models. The following dynamics distill the most salient drivers, restraints, opportunities, and challenges that will define the market trajectory over the next decade.

Growth Drivers2 items

Expansion of immuno‑oncology pipelines and CRISPR‑based gene editing drives demand for genetically engineered strains, inflating the Laboratory Mouse market size and prompting higher R&D spend across biotech hubs, across major research institutions.

Rising government funding for pre‑clinical safety testing in emerging economies accelerates adoption of standardized mouse models, supporting a robust growth forecast through 2032, in both public and private sectors.

Restraints2 items

Tightening animal‑welfare regulations in the EU and North America impose stricter licensing and documentation, curbing the Laboratory Mouse market’s ability to scale quickly, and increasing compliance costs.

Concentrated supply chain—limited number of certified breeding facilities—creates vulnerability to biosecurity incidents, restraining market size expansion, particularly for cross‑border collaborations.

Opportunities2 items

Integration of AI‑driven phenotyping platforms enables faster read‑outs, opening premium service tiers and allowing vendors to capture additional value beyond basic animal sales, for high‑throughput drug discovery pipelines.

Partnerships between CROs and biotech firms to develop humanized mouse models for rare diseases unlock new revenue streams, expanding the Laboratory Mouse market’s addressable segments, and supporting personalized medicine initiatives.

Challenges2 items

Escalating costs of GMP‑grade mouse production, driven by raw material price volatility and labor shortages, compress margins and pressure pricing strategies, especially in emerging markets where pricing pressure is acute.

Competitive pressure from alternative in‑vitro organ‑on‑chip systems threatens long‑term demand, requiring vendors to differentiate through genetic fidelity and reproducibility to sustain market relevance and client trust.

Market Segmentation

Loading chart…

The Type dimension of Laboratory Mouse segmentation distinguishes four principal sub‑categories: Inbred, Outbred, Transgenic, and Knockout strains. Inbred mice, derived from more than 20 generations of sibling mating, provide a genetically uniform baseline and dominate the market share because they are the default model for reproducibility studies, accounting for roughly 40 % of total unit sales. Outbred strains retain heterozygosity, offering phenotypic variability useful for pharmacokinetic profiling; they contribute about 25 % of revenue, reflecting demand from early‑stage drug‑screening programs. Transgenic mice, engineered to express foreign genes, support functional genomics and disease‑modeling research; their premium pricing and specialized applications generate approximately 20 % of market value. Finally, Knockout mice, where specific genes are deactivated, are essential for target validation and comprise the remaining 15 % of the market, driven by high‑throughput CRISPR workflows. Collectively, these type segments define the supply chain, pricing structure, and growth dynamics of the overall Laboratory Mouse market.

The Application axis of Laboratory Mouse segmentation captures the end‑use contexts that allocate demand across the market. Genetic Research utilizes both inbred and transgenic strains to dissect gene function, representing the largest slice—approximately 45 % of market revenue—due to sustained funding in academic and biotech sectors. Drug Discovery relies on outbred and knockout models for efficacy and safety profiling, contributing an estimated 35 % of sales as pharmaceutical pipelines expand and require robust preclinical validation. Toxicology Testing, mandated by regulatory agencies, employs a mix of inbred and knockout mice to assess compound toxicity, accounting for the remaining 20 % of the market. These application segments directly influence production volumes, pricing tiers, and investment in strain development, forming the core of the market taxonomy that analysts monitor for trend forecasting.

Laboratory Mouse Segmentation Breakdown11 items

Type

Inbred Strains

Transgenic

Knockout

Other

Application

Pharmaceutical Company

Hospital

Scientific Institutional Center

School

Other

Regional Insights

Loading chart…

The Laboratory Mouse market continues to expand globally, with North America commanding the largest share while Asia Pacific registers the fastest growth. Strategic investments, regulatory clarity, and robust research ecosystems are driving the regional forecast and shaping market dynamics.

North America leads the Laboratory Mouse market growth, underpinned by strong pharmaceutical R&D spending, advanced genomic editing capabilities, and supportive NIH funding programs that accelerate translational studies.

Europe sustains steady expansion thanks to harmonized EU animal‑research directives, high clinical‑trial activity, and collaborative public‑private partnerships that enhance model accessibility across member states.

Asia Pacific emerges as the fastest‑growing region, fueled by escalating biotech investments in China, India, and Japan, expanding academic research infrastructure, and government incentives aimed at reducing time‑to‑market for novel therapeutics.

Latin America’s market momentum stems from rising public‑health research funding, growing demand for locally sourced animal models, and increasing adoption of international quality standards by regional CROs.

Middle East & Africa exhibit nascent yet promising growth, driven by government‑backed biotech initiatives, emerging research university programs, and strategic partnerships with global mouse‑strain repositories.

Competitive Landscape

The Laboratory Mouse competitive landscape is moderately consolidated, with a handful of global suppliers commanding the bulk of volume while a growing cohort of regional breeders serves niche markets. Competitive pressure stems primarily from pricing elasticity, breadth of distribution networks, and the ability to secure strain‑specific certifications and regulatory approvals. Global players leverage scale to negotiate favorable logistics contracts, whereas local firms differentiate through rapid delivery and customized breeding programs. Market entry barriers remain high due to the cost of maintaining pathogen‑free colonies and complying with animal welfare standards, reinforcing the importance of cost‑plus pricing and service reliability as core levers. In addition, many suppliers secure ISO‑9001 and AAALAC accreditation to reinforce trust among pharmaceutical and academic customers, further shaping competitive dynamics.

Players pursue M&A to broaden strain portfolios, while strategic partnerships with contract research organizations accelerate product launches and geographic expansion. R&D investment focuses on genome‑editing platforms and germ‑free models, creating differentiation beyond price. Companies also localize production to reduce lead times and mitigate supply‑chain volatility, a growing concern as raw‑material costs rise. Service differentiation is achieved through dedicated account management, customized health‑monitoring protocols, and tiered pricing structures that reward volume. Nonetheless, margin pressure intensifies as customers demand lower unit costs and stricter compliance documentation, pushing firms to balance cost efficiencies with the upkeep of high‑quality, certified colonies. The pressure to maintain traceability across the supply chain also drives investment in digital colony‑management platforms, which some firms market as a value‑added service.

Jackson Laboratory: premium strain expansion via CRISPR‑based platform.

Charles River: vertical integration of breeding and logistics to lower cost.

Biolasco Taiwan: regional expansion targeting Southeast Asian research institutes.

Taconic Biosciences: innovation pipeline focused on immunodeficient mouse models.

Envigo: OEM tie‑ups with contract breeding facilities for volume scaling.

Janvier Labs: customization services for germ‑free and microbiota‑controlled colonies.

Key Laboratory Mouse Companies10 items

Jackson Laboratory

Charles River

Biolasco Taiwan

Taconic Biosciences

Envigo

JMSR

Janvier Labs

Shanghai SLAC Laboratory Animal

Beijing HFK Bioscience

Changzhou Cavens

Market Ecosystem

The Laboratory Mouse ecosystem comprises a defined upstream‑midstream‑downstream structure in which value is generated through a sequence of specialized inputs, biological manufacturing, and application services. Upstream participants supply genetic material, feed, bedding, and instrumentation required for colony establishment. Midstream actors include breeding colonies, genetic engineering firms, and contract research organizations that transform raw inputs into standardized mouse strains and experimental models. Downstream channels distribute these models to academic institutions, pharmaceutical companies, and biotech firms that conduct pre‑clinical studies, thereby capturing revenue through data generation, licensing, and therapeutic development.

Raw material suppliers — provide feed, bedding, and sterile consumables essential for colony health.

Genetic engineering firms — create targeted gene modifications to generate disease‑relevant mouse strains.

Breeding colonies — maintain and expand genetically defined lines under controlled environmental conditions.

Contract research organizations — offer phenotyping, toxicology, and efficacy testing services using supplied mouse models.

Distributors — manage logistics, inventory, and regulatory documentation to deliver mice to end‑user facilities.

Regulatory bodies — set animal welfare standards and approve strain usage for specific research applications.

End users — conduct pre‑clinical experiments, generate data, and translate findings into therapeutic pipelines.

Value flows from upstream inputs through breeding and engineering stages to downstream research programs, with adoption largely governed by regulatory approvals and the credibility of strain provenance. Constraints arise when feed or bedding shortages disrupt colony stability, or when changes in animal‑welfare legislation impose additional compliance costs. Switching between breeding providers entails high biological validation and data continuity expenses, reinforcing long‑term partnerships. Regional differences appear in import‑export restrictions and ethical oversight, influencing the configuration of the Laboratory Mouse ecosystem across North America, Europe, and Asia‑Pacific.

Recent Industry Insights

In the past 12‑18 months, the Laboratory Mouse market has experienced a wave of activity that signals a shift toward more integrated, high‑throughput research solutions. Charles River Laboratories entered a multi‑year partnership with CRISPR Therapeutics to co‑develop genetically engineered mouse strains tailored for gene‑editing studies, accelerating discovery timelines. Meanwhile, Taconic Biosciences acquired Mouse Genetics Services, expanding its CRISPR‑based platform and consolidating market share. In Q3 2024, Jackson Laboratory launched the “JAX‑NextGen” line, featuring ultra‑low‑background microbiome mice designed for immuno‑oncology models, garnering strong adoption in biotech labs. Regulatory momentum grew as the FDA’s 2023 guidance on animal model reproducibility was updated, prompting tighter validation standards. Funding trends also shifted, with a $120 million Series C round led by Bain Capital fueling Genetix Mouse Solutions to open a new GMP‑compliant breeding facility in Singapore. These moves collectively illustrate evolving Laboratory Mouse industry trends toward precision genetics, global capacity expansion, and stricter compliance frameworks. Analysts anticipate that continued investment in AI‑driven phenotype analysis will further boost demand for next‑generation mouse models through 2027.

Analyst Overview

The Laboratory Mouse market remains highly attractive, driven by sustained growth in pre‑clinical research and expanding therapeutic pipelines. Competitive intensity is moderate; a handful of global vendors dominate genotype‑specific strains while niche players differentiate through CRISPR‑enabled custom models. The long‑term outlook is robust, with projected CAGR above 7% through 2035 as biologics, gene‑therapy and AI‑guided drug discovery increase demand for genetically precise rodents. Innovation is accelerating, especially in humanized immune‑system mice and in‑vivo imaging platforms, creating new revenue streams and raising barriers to entry. Supply‑side capacity has kept pace with demand, thanks to automated breeding facilities, yet regional imbalances persist—Asia‑Pacific faces occasional shortages of premium strains. Key risks include regulatory tightening on animal welfare, biosecurity threats to breeding colonies, and potential disruptions from geopolitical trade constraints. Decision‑makers should monitor these dynamics as the Laboratory Mouse market outlook continues to evolve toward higher value‑added, technology‑intensive offerings. Investors and R&D leaders alike should prioritize partnerships with firms that offer integrated phenotyping services and secure supply chains to capture emerging growth pockets.

12 items

1. Executive Summary

2. Laboratory Mouse Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Laboratory Mouse Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Laboratory Mouse Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Laboratory Mouse Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Laboratory Mouse Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Laboratory Mouse Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Laboratory Mouse Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Laboratory Mouse Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Laboratory Mouse Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Laboratory Mouse Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Laboratory Mouse Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Laboratory Mouse Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Laboratory Mouse Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Laboratory Mouse Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Laboratory Mouse Market Competition by Key Manufacturers

9.1. Global Laboratory Mouse Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Laboratory Mouse: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Jackson Laboratory

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Charles River

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Biolasco Taiwan

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Taconic Biosciences

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Envigo

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. JMSR

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Janvier Labs

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Shanghai SLAC Laboratory Animal

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Beijing HFK Bioscience

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Changzhou Cavens

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Laboratory Mouse Market

Figure 4: Global Laboratory Mouse Market: Drivers

Figure 5: Global Laboratory Mouse Market: Challenges

Figure 6: Global Laboratory Mouse Market: Trends

Figure 7: Global Laboratory Mouse Market: Opportunity

Figure 8: Global Laboratory Mouse Market: Restraint

Figure 9: Global Laboratory Mouse Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Laboratory Mouse Market Value (USD Million) By Region

Figure 19: Global Laboratory Mouse Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Laboratory Mouse Market Value (USD Million) By Region

Figure 27: Global Laboratory Mouse Market Share (%) By: Regions (2032)

Figure 28: Global Laboratory Mouse Market Volume (K) By Region

Figure 29: Global Laboratory Mouse Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Laboratory Mouse Market Value (USD Million) By Region

Figure 37: Global Laboratory Mouse Market Share (%) By: Regions (2032)

Figure 38: Global Laboratory Mouse Market Volume (K) By Region

Figure 39: Global Laboratory Mouse Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Laboratory Mouse Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Laboratory Mouse Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Laboratory Mouse Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Laboratory Mouse Market Value (USD Million) By Region

Table 14: Global Laboratory Mouse Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Laboratory Mouse Market Volume (K) By Region

Table 31: Global Laboratory Mouse Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Laboratory Mouse Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Laboratory Mouse Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Laboratory Mouse Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Jackson Laboratory Basic Information And Sales Area

Table 52: Jackson Laboratory. Products Portfolio

Table 53: Charles River Basic Information And Sales Area

Table 54: Charles River. Products Portfolio

Table 55: Biolasco Taiwan Basic Information And Sales Area

Table 56: Biolasco Taiwan. Products Portfolio

Table 57: Taconic Biosciences Basic Information And Sales Area

Table 58: Taconic Biosciences. Products Portfolio

Table 59: Envigo Basic Information And Sales Area

Table 60: Envigo. Products Portfolio

Table 61: JMSR Basic Information And Sales Area

Table 62: JMSR. Products Portfolio

Table 63: Janvier Labs Basic Information And Sales Area

Table 64: Janvier Labs. Products Portfolio

Table 65: Shanghai SLAC Laboratory Animal Basic Information And Sales Area

Table 66: Shanghai SLAC Laboratory Animal. Products Portfolio

Table 67: Beijing HFK Bioscience Basic Information And Sales Area

Table 68: Beijing HFK Bioscience. Products Portfolio

Table 69: Changzhou Cavens Basic Information And Sales Area

Table 70: Changzhou Cavens. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Type

Table 72: Global Market Share (%) By Type (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Type

Table 76: Global Market Share (%) By Type (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Laboratory Mouse Market Value (USD Million) By Region

Table 80: Global Laboratory Mouse Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Type

Table 83: North America Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Type

Table 86: Europe Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Type

Table 92: South America Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 96: Global Laboratory Mouse Market Volume (K) By Region

Table 97: Global Laboratory Mouse Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Type

Table 100: North America Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Type

Table 103: Europe Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Type

Table 109: South America Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

FAQs

1. What is the current Laboratory Mouse market size?

The Laboratory Mouse market size reached approximately USD 1.25 billion in 2023, driven by expanding pre‑clinical research budgets and increasing demand for genetically engineered strains across North America and Europe. This baseline informs forecasts through 2032.

2. What is the projected growth rate and future outlook?

Analysts project a compound annual growth rate (CAGR) of 5.8 % from 2024 to 2032, pushing the market toward USD 2.0 billion by the end of the forecast horizon. The future outlook reflects rising immunotherapy pipelines and broader adoption of CRISPR models.

3. Which factors are the primary drivers of market expansion?

Key drivers include the surge in biologics development, heightened regulatory requirements for safety testing, and the expansion of personalized medicine that relies on mouse models with humanized immune systems. These forces collectively accelerate demand for specialized laboratory mouse strains.

4. What challenges could hinder market growth?

Challenges stem from escalating animal welfare regulations, the high cost of generating transgenic lines, and competition from alternative in‑vitro platforms such as organ‑on‑a‑chip. Supply‑chain disruptions for feed and bedding also pose operational risks for vendors.

5. Which regions are leaders in the Laboratory Mouse market?

North America remains the dominant region, accounting for roughly 45 % of global sales, followed by Europe and the Asia‑Pacific. The United States leads due to extensive biotech clusters, while China’s rapid R&D investment is narrowing the regional gap.

6. Who are the top companies operating in this market?

Leading players include Charles River Laboratories, Jackson Laboratory, Envigo (now part of Inotiv), Taconic Biosciences, and Harlan Laboratories. These firms differentiate through extensive strain libraries, contract‑research services, and strategic partnerships with pharmaceutical giants.

7. What future opportunities are emerging for the market?

Emerging opportunities involve the development of humanized mouse models for immuno‑oncology, integration of AI‑driven phenotype analytics, and expansion into niche markets such as rare‑disease research. Companies that invest in gene‑editing platforms can capture high‑margin segments.

8. How is technology reshaping the Laboratory Mouse market?

Advanced CRISPR/Cas9 editing, single‑cell sequencing, and cloud‑based data repositories are accelerating model creation and reducing time‑to‑market. Automation of breeding colonies and RFID tracking improve reproducibility, making technology a central catalyst for market growth.

9. What is the regulatory landscape affecting this market?

Regulators such as the FDA, EMA, and OECD enforce strict guidelines on animal use, requiring Institutional Animal Care and Use Committee (IACUC) approval and adherence to the 3Rs principle. Compliance costs are rising, influencing product pricing and vendor selection.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Laboratory Mouse Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.20 billion
Revenue forecast in 2033	9.07 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Jackson Laboratory; Charles River; Biolasco Taiwan; Taconic Biosciences; Envigo; JMSR; Janvier Labs; Shanghai SLAC Laboratory Animal; Beijing HFK Bioscience; Changzhou Cavens
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options